Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CATS: Cardiovascular Safety Follow-up for Smoking Cessation Treatments
NCT01574703Phase 4Completed
- Sponsor
- Pfizer
- Start
- May 2012
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 16
01
Overview
Phase 4, randomised, double-blind trial of varenicline + nicotine patch in nicotine dependence, sponsored by Pfizer. Started May 2012; status: completed.
02
Drugs
varenicline + nicotine patch
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01574703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01574703.